{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-101773","form_type":"8-K","ticker":"REPL","cik":"0001737953","company_name":"Replimune Group, Inc.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.050109+00:00","generated_at":"2026-06-10T13:37:25.890290+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Replimune names Emily Hill as CFO; previously CFO of PTC Therapeutics","bullets":["Appointed Emily Hill as CFO effective Sept 18, 2023; she was previously CFO of PTC Therapeutics.","Base salary $495,000, target bonus 40%, plus 125,000 stock options at $18.00 and 83,330 RSUs, vesting over 4 years.","Termination benefits: 12 months salary plus COBRA; enhanced upon change of control.","Ms. Hill brings 15+ years biotech experience, including roles at PTC, Warner Chilcott, and Genzyme."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-101773","json":"https://secwatch.observer/filing/0001104659-23-101773.json","markdown":"https://secwatch.observer/filing/0001104659-23-101773.md","text":"https://secwatch.observer/filing/0001104659-23-101773.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/0001104659-23-101773-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/tm2326363d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:37:25.890290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6db9ea94d9","claim":"Emily Hill was appointed as Chief Financial Officer at Replimune Group, Inc..","evidence_excerpt":"On September 19, 2023, Replimune Group, Inc. (“Replimune”) announced the appointment of Emily Hill as its Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/0001104659-23-101773-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}